Item 2.02 Results of Operations and Financial Condition

On August 12, 2021, Angion Biomedica Corp., a Delaware corporation (the "Company"), issued a press release announcing the Company's financial results for the fiscal quarter ended June 30, 2021. The press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

The information furnished with this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits



(d) Exhibits

   Exhibit                                              Exhibit
    Number                                            Description
          99.1         Press release dated Aug 12, 2021 relating to the financial results for the
                     fiscal quarter ended June 30, 2021.
           104       Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses